
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above for a link to open the Pharmaceutical Executive November 2020 issue in an interactive PDF format.
about 6 years ago
Synthetic Biology and the Environmentabout 6 years ago
Measuring Pharma’s Wider Mandateabout 6 years ago
Patients as the North Starabout 6 years ago
A Rare-Disease Must? Building Long-Term Relationshipsabout 6 years ago
Making Remote Work a Success Beyond COVIDabout 6 years ago
CRISPR for Diversity, and Humanity’s, Sakeabout 6 years ago
Expediting the Cancer Treatment Pathabout 6 years ago
Vaccine Authorization, Distribution Raise Multiple Challengesabout 6 years ago
EU Leaders in High-Stakes Gamble on COVID Responses





